Dr. Jonathan Downar, Psychiatrist and Associate Professor at the University of Toronto, joins neurocare’s Dr. Trevor Brown to discuss a groundbreaking new approach to Transcranial Magnetic Stimulation (TMS). The "ONE-D Trial" explores an accelerated, single-day TMS protocol designed to optimize neuroplasticity and enhance treatment outcomes for depression.

Unlike traditional TMS protocols requiring weeks of daily sessions, the ONE-D protocol delivers 20 sessions of intermittent theta burst stimulation (iTBS) over a single day, combined with D-cycloserine to boost neuroplasticity. Early findings indicate a delayed but robust treatment response, with remission rates increasing over six weeks post-treatment.

In this conversation, Dr. Downar explains the methodology, patient selection, and future implications of this innovative approach. They discuss how the ONE-D protocol compares to existing accelerated methods like the Stanford SAINT protocol and explore its potential applications for OCD, anxiety, and neurodegenerative disorders such as Parkinson’s and Alzheimer’s disease.

About Dr. Jonathan Downar
Dr. Downar is an Associate Professor at the University of Toronto and a leading researcher in neuromodulation and accelerated TMS protocols. His work focuses on refining non-invasive brain stimulation techniques to improve accessibility and clinical efficacy.

About the series
The neurocare group is a global network of experts in neuroscience, psychology, and neuromodulation, dedicated to advancing mental health and performance science. In this interview series, neurocare Academy lead Dr Trevor Brown interviews leading minds in this field on the state of research and effective models of care in mental health and cognitive performance. To learn more about the neurocare group and its mission visit www.neurocaregroup.com.

Are you a practitioner interested in learning how you can apply TMS and other neuromodulation techniques in your own practice? Get started with one of our online courses in neuromodulation at: www.lms.neurocaregroup.com. neurocare academy also offers in-person training and supervision in workshops throughout the world. For more information visit: www.neurocaregroup.com/academy/

If you are a patient looking for more information about these techniques or to find one of our clinics worldwide, visit www.neurocaregroup.com/patients/

#TMS #rTMS #MagneticStimulation #TranscranialMagneticStimulation #Neurostimulation #ClinicalCare #Psychiatry #neuroscience #MentalHealth #TMSClinic #DepressionTreatment #HealthcareProfessionals #TMSresearch #iTBS #HealthFrontiers #Neuroplasticity #CognitiveScience

In this episode of NeuroCare Academy, I sit down with Dr. Shan Siddiqi, a psychiatrist and lecturer at Harvard Medical School, to explore the future of psychiatry and neuromodulation. Dr. Siddiqi, a leading researcher in transcranial magnetic stimulation (TMS), shares insights from his latest work on TMS treatment for depression and its potential as an accredited subspecialty in medical education. We discuss the recent Brain Stimulation Subspecialty Summit, where experts aimed to standardize training and promote collaboration between psychiatry, neurology, and neurosurgery. This conversation highlights the importance of TMS in mental health care and the exciting developments on the horizon that could enhance clinical practice and patient outcomes. Tune in to learn more about the future of brain stimulation and its impact on mental health treatment.

Professor Alexander T. Sack, Cognitive Neuroscientist at Maastricht University, discusses how our understanding of the working mechanisms behind Transcranial Magnetic Stimulation (TMS) is evolving and what this means for improving clinical outcomes. Rather than focusing solely on precise stimulation sites using fMRI, Prof. Sack explains why optimizing the timing of pulses with EEG guidance may be key to enhancing treatment success.

In this conversation with Dr. Trevor Brown, Neuroscientist at neurocare group, they explore the importance of keeping a patient’s brain state active and consistent before and during TMS. By aligning treatment with brain-state dynamics, clinicians may be able to significantly increase therapeutic benefits.

Watch as they discuss the future of TMS, the science behind its working mechanisms, and how these insights could refine clinical practice for better patient outcomes.

About Prof. Alexander T. Sack:
Professor of Cognitive Neuroscience at Maastricht University, Prof. Alexander T. Sack specializes in non-invasive brain stimulation, particularly TMS and EEG, to study and enhance cognitive functions and clinical treatments.

About the series
The neurocare group is a global network of experts in neuroscience, psychology, and engineering, with a mission to empower best practices and bring innovative and sustainable mental health techniques to more patients in need through our network of clinics.

Through this interview series, the head of the neurocare Academy, Dr Trevor Brown, interviews leading minds in this field, to present the state of research and possibilities and effective models of care in mental health and cognitive performance.

To learn more about the neurocare group and its mission visit www.neurocaregroup.com

If you are a patient looking for more information about these techniques or to find one of our clinics worldwide, visit www.neurocaregroup.com/patients/

Are you a practitioner interested in learning how you can apply TMS and other neuromodulation techniques in your own practice?
Get started with one of our online courses in neuromodulation at: www.lms.neurocaregroup.com

neurocare academy also offers in-person training and supervision in workshops throughout the world. For more information visit: www.neurocaregroup.com/academy/


#TMS #rTMS #MagneticStimulation #TranscranialMagneticStimlation #Neurostimulation #ClinicalCare #Psychiatry #Nursing #psychology #neuroscience #MentalHealth #TMSClinic #DepressionTreatment #HealthcareProfessionals #ProfessionalSupervision #PatientDoctorRelationship #TherapeuticRelationship

Dr. Phern Chern Tor, Psychiatrist and head of Neurostimulation services at the Institute of Mental Health in Singapore, discusses the practicalities of running a TMS service. He shares insights on avoiding adverse events, managing pain tolerance, assessing suitability for TMS, and monitoring outcomes to ensure patient safety. Dr. Tor also highlights the economic benefits of including TMS in mental health practice, particularly in its role within a cost-effective stepped-care approach for treatment-resistant depression.

In this conversation with Trevor Brown, Dr. Tor emphasizes the importance of a well-trained and responsible clinician, carefully assessing each patient's motivation and history of side effects to reduce the risk of seizures and other adverse effects. He also underscores the value of the therapeutic relationship between the nurse or practitioner and the patient, as this bond plays a critical role in treatment success, improving patient comfort and reducing anxiety.

They also explore the sequencing of treatments for patients with depression, with Dr. Tor explaining how starting TMS treatment gradually can help minimize side effects and optimize outcomes. The discussion reinforces the importance of ongoing clinician support, supervision, and team collaboration to ensure both the safety and well-being of patients throughout the treatment process.

About Dr. P.C. Tor
Dr. Phern Chern Tor, Psychiatrist and head of Neurostimulation services at the Institute of Mental Health in Singapore Phern Chern Tor | LinkedIn
Clinical TMS Society

About the series
The neurocare group is a global network of experts in neuroscience, psychology, and engineering, with a mission to empower best practices and bring innovative and sustainable mental health techniques to more patients in need through our network of clinics.

Through this interview series, the head of the neurocare Academy, Dr Trevor Brown, interviews leading minds in this field, to present the state of research and possibilities and effective models of care in mental health and cognitive performance.

To learn more about the neurocare group and its mission visit www.neurocaregroup.com

If you are a patient looking for more information about these techniques or to find one of our clinics worldwide, visit www.neurocaregroup.com/patients/

Are you a practitioner interested in learning how you can apply TMS and other neuromodulation techniques in your own practice?
Get started with one of our online courses in neuromodulation at: www.lms.neurocaregroup.com

neurocare Academy also offers in-person training and supervision in workshops throughout the world. For more information visit: www.neurocaregroup.com/academy/

Chapters

00:00 Introduction and Background
03:03 Getting to Know Dr. Phern Chern Tor
06:52 Setting Up TMS Services in Singapore
10:04 Reimbursement for TMS in Singapore
17:21 Three People Dr. Tor Would Invite for Dinner
18:49 Adverse Events and Risk Management in TMS
29:07 Setting Up a TMS Clinic: Education and Team Building
45:09 The Importance of the Therapeutic Relationship in TMS
52:29 Cost-Effectiveness of TMS in Comparison to Other Treatments
56:17 Sequencing Treatments for Depression: Antidepressants, TMS, and ECT

#TMS #rTMS #MagneticStimulation #TranscranialMagneticStimlation #Neurostimulation #ClinicalCare #Psychiatry #Nursing #psychology #neuroscience #MentalHealth #TMSClinic #DepressionTreatment #HealthcareProfessionals #ProfessionalSupervision #PatientDoctorRelationship #TherapeuticRelationship

In our latest podcast, neurocare’s Dr. Trevor Brown interviews Dr. Tomas Ros, a neuroscientist at the Center for Biomedical Imaging, University of Geneva. Dr. Ros shares groundbreaking insights into neurofeedback and EEG microstates in diagnosing and treating mental health disorders. They discuss personalized neurofeedback protocols for ADHD, emphasizing the need for tailored treatments based on specific brain biomarkers and the potential of EEG microstates to improve clinical outcomes. Dr. Ros also explores neurofeedback for PTSD, highlighting promising results in altering brain wave patterns to alleviate symptoms, while noting the necessity for further research before widespread clinical implementation.

Dr. Ros’s work underscores the diagnostic potential of EEG microstates for ADHD, PTSD, and schizophrenia, offering new avenues for personalized treatment. He envisions a future where neurofeedback and EEG analysis are integral to mental health care, with advancements in technology and machine learning enhancing the precision and effectiveness of these interventions. This conversation is invaluable for professionals and patients seeking to understand the transformative potential of these innovative approaches in improving mental health outcomes.


About the series:

The neurocare group is a global network of experts in neuroscience, psychology, and engineering, with a mission to empower best practices and bring innovative and sustainable mental health techniques to more patients in need through our network of clinics.

Through this interview series, the head of the neurocare Academy, Dr Trevor Brown, interviews leading minds in this field, to present the state of research and possibilities and effective models of care in mental health and cognitive performance.

#Neurofeedback, #ADHD, #EEG, #PTSD, #Biomarkers, #Psychiatry, #Treatments, #BrainFrequencies, #TranscranialMagneticStimulation, #Schizophrenia, #Pharmacotherapy, #ClinicalSymptoms, #RandomizedControlTrials, #PersonalizedInterventions, #TechnologicalAdvancements, #Trauma, #AlphaRhythm, #DefaultModeNetwork, #Hypervigilance, #SensoryProcessing, #PrefrontalCortex, #AnteriorCingulate, #EmotionalStates, #HomeostaticAdaptation, #BrainRegions, #Meditation, #EEGAnalysis, #CognitiveFunction, #AI, #MachineLearning, #QuantitativeEEG, #PsychiatricDisorders, #NeurologicalDisorders, #CognitiveRegulation

To learn more about the neurocare group and its mission visit www.neurocaregroup.com

If you are a patient looking for more information about these techniques or to find one of our clinics worldwide, visit www.neurocaregroup.com/patients/

Are you a practitioner interested in learning how you can apply TMS and other neuromodulation techniques in your own practice?

Learn from the experts at neurocare Academy on our LMS (lms.neurocaregroup.com)

neurocare Academy also offers in-person training and supervision in workshops throughout the world. For more information visit: www.neurocaregroup.com/academy/

In our latest Podcast release, neurocare’s Dr. Trevor Brown interviews TMS expert Dr. Jonathan Downar, Associate Professor of Psychiatry at the University of Toronto.

Dr. Downar delves into the neural mechanisms underlying resilience, survival, and their connection to effective depression treatments like Transcranial Magnetic Stimulation (TMS). He highlights the critical role of the left dorsolateral prefrontal cortex in adaptive responses and executive functions, such as decision-making and problem-solving.

This insightful conversation is valuable for medical and mental healthcare professionals seeking to understand the practical implications of TMS in clinical settings, as well as for patients wanting to learn more about TMS therapy and its potential benefits.

About Dr. Jonathan Downar:

Dr. Jonathan Downar is an Associate Professor of Psychiatry at the University of Toronto, specializing in neuromodulation and TMS therapy. His research focuses on understanding the brain's mechanisms for resilience and survival, and developing innovative treatments for mental health conditions.

About the series:

The neurocare group is a global network of experts in neuroscience, psychology, and engineering, with a mission to empower best practices and bring innovative and sustainable mental health techniques to more patients in need through our network of clinics.

Through this interview series, the head of the neurocare Academy, Dr Trevor Brown, interviews leading minds in this field, to present the state of research and possibilities and effective models of care in mental health and cognitive performance.

#neuralcircuitry, #courage, #resilience, #survival, #brainmechanisms, #TMS #neurostimulation #neuromodulation

To learn more about the neurocare group and its mission visit www.neurocaregroup.com

If you are a patient looking for more information about these techniques or to find one of our clinics worldwide, visit www.neurocaregroup.com/patients/

Are you a practitioner interested in learning how you can apply TMS and other neuromodulation techniques in your own practice?

Learn from the experts at neurocare Academy on our LMS (lms.neurocaregroup.com)

neurocare Academy also offers in-person training and supervision in workshops throughout the world. For more information visit: www.neurocaregroup.com/academy/

neurocare’s Dr. Trevor Brown speaks with Dr. Jonathan Downer, a psychiatrist and associate professor at the University of Toronto, focusing on the use of repetitive transcranial magnetic stimulation (rTMS or TMS) for psychiatric disorders. Dr. Downer emphasizes the importance of personalized TMS treatment tailored to specific neural circuitry in psychiatric disorders. The discussion explores different stimulation targets within the brain and highlights the safety and tolerability of TMS across various areas.

The researchers also discuss the efficiency of TMS (rTMS) treatments, particularly with the use of intermittent Theta Burst stimulation (iTBS), making the therapy more accessible to patients. Dr. Downer focuses on the need for enhanced accessibility and affordability, emphasizing the importance of refining systems and processes to broaden access to TMS for patients with depression. Looking ahead, Dr. Downer predicts a future in neuromodulation involving faster, more cost-effective treatments, extending the applications of brain stimulation to conditions like Alzheimer's and Parkinson's. The discussion emphasizes the vital role of ongoing research in refining TMS efficacy and understanding its impact on diverse brain areas and disorders. This discussion offers a comprehensive overview of the current state and future potential of TMS therapy in the realm of psychiatric disorders.

---

Are you a practitioner interested in learning how you can apply neuromodulation techniques in your own practice?


Join the neurocare academy LMS and start an online certification or accreditation course online.

rTMS in Depression, OCD & New Developments: https://lms.neurocaregroup.com/shop/rtms-in-depression-ocd-new-developments-course-registration/

An Introduction to tDCS: https://lms.neurocaregroup.com/shop/an-introduction-to-tdcs-course-registration/

Neurofeedback in ADHD & Insomnia: https://lms.neurocaregroup.com/shop/neurofeedback-in-adhd-insomnia-course-registration/

neurocare Academy also offers in-person training and supervision in workshops throughout the world. For more information visit: www.neurocaregroup.com/academy/

----

The neurocare group is a global network of experts in neuroscience, psychology, engineering, with a mission to empower best practice and bring innovative and sustainable mental health techniques to more patients in need through our network of clinics.

Through this interview series, the head of the neurocare Academy, Dr Trevor Brown, interviews leading minds in this field, to present the state of research and possibilities and effective models of care in mental health and cognitive performance.

To learn more about the neurocare group and its mission visit www.neurocaregroup.com

If you are a patient looking for more information about these techniques or to find one of our clinics worldwide, visit www.neurocaregroup.com/patients/

In recent years, the non-invasive neurostimulation treatment, Transcranial Magnetic Stimulation, or ‘TMS’, has been gaining recognition as a viable and evidence-based medical alternative for patients suffering Depression who are not responding adequately to first line treatments, such as medication.

The benefits of this treatment and how to best apply it, is being validated now in elderly populations. Dr. Albino Oliveira-Maia, researcher, and director at NOVA Medical School in Portugal, runs a clinical unit focused on providing innovative mental health treatments for cancer patients and patients with Depression and OCD who have not been helped by other methods.

Here they provide TMS in combination with other treatments and explore the positive effects and outcomes in a wide-ranging patient population, including those in geriatric care. neurocare’s Dr Trevor Brown speaks with Dr Oliveira-Maia to learn more about his research and outlook for TMS and how the method can be improved and better utilized, such as the effects of ‘maintenance’ sessions and how well TMS works in elderly.

Albino is very active in pushing for TMS and other anti-depressant treatments to become part of standard care and discusses the current limitations of mental health care in Portugal and Europe at large, and how they can be improved.

This interview may interest researchers, scientists, clinicians, and students working or studying in the field of mental healthcare. Although the conversation here centers around more scientific concepts, it may also interest a wider audience interested in learning more about the treatment approach of TMS in depression.


---

Are you a practitioner interested in learning how you can apply neuromodulation techniques in your own practice?


Join the neurocare academy LMS and start an online certification or accreditation course online.

rTMS in Depression, OCD & New Developments: https://lms.neurocaregroup.com/shop/rtms-in-depression-ocd-new-developments-course-registration/

An Introduction to tDCS: https://lms.neurocaregroup.com/shop/an-introduction-to-tdcs-course-registration/

Neurofeedback in ADHD & Insomnia: https://lms.neurocaregroup.com/shop/neurofeedback-in-adhd-insomnia-course-registration/

neurocare Academy also offers in-person training and supervision in workshops throughout the world. For more information visit: www.neurocaregroup.com/academy/

----

The neurocare group is a global network of experts in neuroscience, psychology, engineering, with a mission to empower best practice and bring innovative and sustainable mental health techniques to more patients in need through our network of clinics.

Through this interview series, the head of the neurocare Academy, Dr Trevor Brown, interviews leading minds in this field, to present the state of research and possibilities and effective models of care in mental health and cognitive performance.

To learn more about the neurocare group and its mission visit www.neurocaregroup.com

If you are a patient looking for more information about these techniques or to find one of our clinics worldwide, visit www.neurocaregroup.com/patients/